Buscar resultados de ensayos clínicos
Schistosomiasis - 29 Studies Found
| Estado | Estudiar |
| Completed |
Nombre del estudio: Clinical Trial of Bilhvax,a Vaccine Candidate Against Schistosomiasis Condición:
Fecha: 2012-01-09 Intervenciones: Biological: rSh28GST subcutaneous route at Day 0, Day 28, and Day 150 for the third administration of 10 |
| Completed |
Nombre del estudio: Efficacy of Bilhvax in Association With Praziquantel for Prevention of Clinical Recurrences of Schistosoma Haematobium Condición:
Fecha: 2009-03-26 Intervenciones:
|
| Completed |
Nombre del estudio: Urogenital Schistosomiasis and Sexually Transmitted Infections in Madagascar Condición:
Fecha: 2008-07-08 Intervenciones: Drug: Treatment with anti-STI and anti-schistosoma regimens Anti-STI regimen: ciprofloxacin 500mg orally |
| Completed |
Nombre del estudio: Effect of Schistosomiasis Mansoni on HIV Susceptibility and Female Genital Immunology Condición:
Fecha: 2016-08-15 Intervenciones: Drug: Praziquantel 40 mg/kg, PO (orally administered tablets) |
| Completed |
Nombre del estudio: Evaluation of the Use of a Urin Test Strip to Determine the Spread of Schistosoma Infections in Areas Where Schistosomiasis Infections Are Low in Kenya Condición:
|
| Completed |
Nombre del estudio: Treatment Schistosomal Portal Hypertension: Efficacy of Endoscopy or Surgery Condición:
|
| Completed |
Nombre del estudio: Schistosoma Mansoni Morbidity in Children Aged 1-5 Years Condición: Intestinal Schistosomiasis Fecha: 2013-05-30 Intervenciones: Drug: Praziquantel All the registered S. mansoni infected children aged 1-5 years will be randomly divid |
| Completed |
Nombre del estudio: Trial to Investigate the Effect of Schistosoma Mansoni Infection on the Response to Vaccination With MVA85A in BCG-vaccinated African Adolescents Condición: Tuberculosis Fecha: 2014-06-03 Intervenciones: Biological: MVA85A Single dose of 1x10^8pfu MVA85A intramuscular vaccination |
| Completed |
Nombre del estudio: Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS Condición: HIV/AIDS Fecha: 2014-07-18 Intervenciones:
|